Certificate under reg. 74(5) for the quarter ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samrat Pharmachem Limited has submitted a certificate under SEBI Regulation 74(5) for the quarter ended September 30, 2025. The certificate was issued by the company's Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited. It confirms that all securities received from depository participants for demat during the quarter were properly accepted or rejected by the depositories, listed on the stock exchanges, and recorded in the register of members within the prescribed timelines. The original share certificates were mutilated and cancelled as per the standard process. This is a routine quarterly compliance filing, not a corporate action or material event.
No material impact on shareholders or the stock price. This is a standard regulatory compliance requirement confirming the smooth processing of dematerialization requests during the quarter, indicating normal share transfer and depository operations.